北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in postmenopausal women: a randomized clinical trial in Beijing
作者: Zheng, SR; Wu, YY; Zhang, ZL; Yang, X; Hui, Y; Zhang, Y; Chen, SL; Deng, WH; Liu, H; Stocks, AEJ; Harper, K; Liu, JL
关键词: raloxifene ; bone mineral density ; metabolism ; lipids ; postmenopause
刊名: CHINESE MEDICAL JOURNAL
发表日期: 2003-08-01
卷: 116, 期:8, 页:1127-1133
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, General & Internal
研究领域[WOS]: General & Internal Medicine
关键词[WOS]: HORMONE REPLACEMENT THERAPY ; VERTEBRAL FRACTURE RISK ; BREAST-CANCER ; OSTEOPOROSIS ; ESTROGEN ; ENDOMETRIUM ; REDUCTION ; PLACEBO
英文摘要:

Objective To determine the effects of raloxifene hydrochloride (RLX) on bone mineral density (BMD), bone metabolism markers and serum lipids in healthy postmenopausal women in Beijing.

Methods A multicenter, randomized, double-blind, placebo-controlled study was conducted in a total of 204 healthy postmenopausal women (age 59.5 +/-5.0 years and weight 62.8 +/-8.7 kg) treated with either RLX 60 mg (n = 102) or placebo (n = 102) daily for 12 months. BMD, serum lipids, and bone markers were measured before and after drug administration.

Results Compared with placebo, RLX produced a significant increase in both total lumbar spine and total hip BMD. For the lumbar spine, percentage increase in total BMD was 2.3% with RLX compared with a decrease of 0.1% with placebo (P < 0.001). Corresponding values for total hip BMD were a 2.5% increase for RLX and a 1.1% increase for placebo (P = 0.011). For biochemical markers of bone metabolism, serum osteocalcin and C-telopeptide, percentage decreases were 27.65% and 24.02% in RLX-treated subjects. Corresponding values in placebo were a 10.64% decrease and a 15.75% increase (RLX compared with placebo, both P < 0.001). For total cholesterol and low-density lipoprotein cholesterol levels, percentage decreases were 6.44% and 34.58% in the RLX-treated group. Corresponding values in placebo-treated patients were a 1.44% increase and a 19.07% decrease (RLX compared with placebo, both P < 0.001). No differences were found for high-density lipoprotein cholesterol or triglyceride levels between the two groups. Only 5 subjects discontinued early owing to an adverse event (3 in the RLX group and 2 in the placebo group).

Conclusions This study confirms that RLX exerts positive effects on the skeleton, increasing BMD and decreasing biochemical markers of bone metabolism, and has a positive effect on the overall serum lipid profile in postmenopausal women in China.

语种: 英语
WOS记录号: WOS:000185174400002
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/55628
Appears in Collections:北京大学第一临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Beijing Hosp, Dept Obstet & Gynaecol, Beijing 100730, Peoples R China
2.Eli Lilly & Co, Indianapolis, IN 46285 USA
3.Peking Univ, Dept Obstet & Gynaecol, Hosp 1, Beijing 100034, Peoples R China
4.Gen Hosp PLA, Dept Obstet & Gynaecol, Beijing 100853, Peoples R China

Recommended Citation:
Zheng, SR,Wu, YY,Zhang, ZL,et al. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in postmenopausal women: a randomized clinical trial in Beijing[J]. CHINESE MEDICAL JOURNAL,2003,116(8):1127-1133.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zheng, SR]'s Articles
[Wu, YY]'s Articles
[Zhang, ZL]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zheng, SR]‘s Articles
[Wu, YY]‘s Articles
[Zhang, ZL]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace